Market Research Logo

Sickle Cell Anemia Pipeline Highlights – 2017 Update

Sickle Cell Anemia Pipeline Highlights – 2017 Update

The latest report from Fore Pharma, Sickle Cell Anemia Pipeline Highlights – 2017 Update, provides most up-to-date information on key pipeline products in the global Sickle Cell Anemia market. It covers emerging therapies for Sickle Cell Anemia in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Sickle Cell Anemia pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Sickle Cell Anemia pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Sickle Cell Anemia pipeline products by the company.

Short-term Launch Highlights:
Find out which Sickle Cell Anemia pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:

  • Sickle Cell Anemia phase 3 clinical trial pipeline products
  • Sickle Cell Anemia phase 2 clinical trial pipeline products
  • Sickle Cell Anemia phase 1 clinical trial pipeline products
  • Sickle Cell Anemia preclinical research pipeline products
  • Sickle Cell Anemia discovery stage pipeline products
  • Sickle Cell Anemia pipeline products short-term launch highlights


1. Sickle Cell Anemia Pipeline by Stages
2. Sickle Cell Anemia Pipeline by Drug Class
3. Sickle Cell Anemia Pipeline by Company
4. Sickle Cell Anemia Phase 3 Clinical Trial Insights
5. Sickle Cell Anemia Phase 2 Clinical Trial Insights
6. Sickle Cell Anemia Phase 1 Clinical Trial Insights
7. Sickle Cell Anemia Preclinical Research Insights
8. Sickle Cell Anemia Discovery Stage Insights
9. Appendix
10. Research Methodology
LIST OF TABLES
Table 1: Sickle Cell Anemia Phase 3 Clinical Trials, 2017
Table 2: Sickle Cell Anemia Phase 2 Clinical Trials, 2017
Table 3: Sickle Cell Anemia Phase 1 Clinical Trials, 2017
Table 4: Sickle Cell Anemia Preclinical Research, 2017
Table 5: Sickle Cell Anemia Discovery Stage, 2017
LIST OF FIGURES
Figure 1: Sickle Cell Anemia Pipeline Molecules by Clinical Trials Stage, 2017
Figure 2: Sickle Cell Anemia Pipeline Molecules by Drug Class, 2017
Figure 3: Sickle Cell Anemia Pipeline Molecules by Company, 2017
Figure 4: Sickle Cell Anemia Phase 3 Clinical Trial Highlights, 2017
Figure 5: Sickle Cell Anemia Phase 2 Clinical Trial Highlights, 2017
Figure 6: Sickle Cell Anemia Phase 1 Clinical Trial Highlights, 2017
Figure 7: Sickle Cell Anemia Preclinical Research Highlights, 2017
Figure 8: Sickle Cell Anemia Discovery Stage Highlights, 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report